Suchergebnisse - "Yi, Zongbi"

PubPharm (55)

31

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage

enthalten in: Frontiers in oncology | 2020

von Guan, X. | Ma, F. | Sun, X. | +7

32

Mutational characteristics determined using circulating tumor DNA analysis in triple‐negative breast cancer patients with distant metastasis

enthalten in: Cancer Communications | 2020

von Rong, G. | Yi, Z. | Ma, F. | +4

33

Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China

enthalten in: Cancer Communications | 2020

von Yi, Z. | Ma, F. | Rong, G. | +3

34

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

enthalten in: International Journal of Cancer | 2020

von Ma, F. | Guan, Y. | Yi, Z. | +16

35

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients : A Phase I Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Li, Q. | Guan, X. | Chen, S. | +16

36

Everolimus in hormone receptor-positive metastatic breast cancer : PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

enthalten in: BMC cancer | 2019

von Yi, Z. | Ma, F. | Liu, B. | +5

37

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

enthalten in: BMC cancer | 2019

von Yi, Z. | Ma, F. | Liu, B. | +5

38

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

enthalten in: BMC cancer | 2019

von Yi, Z. | Ma, F. | Liu, B. | +5

39

The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA : a real-world study

enthalten in: Cancer communications (London, England) | 2018

von Liu, B. | An, T. | Li, M. | +10

40

The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study

enthalten in: Cancer communications | 2018

von Liu, B. | An, T. | Li, M. | +10